MIRUM PHARMACEUTICALS INC (MIRM)

US6047491013 - Common Stock

25.8  -0.59 (-2.24%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
19.14M77.06M
302.61%		186.374M
141.86%		323.27M
73.45%
EBITDA
YoY % growth
-172.81M
-66.18%		-127.98M
25.94%		-98.325M
23.17%		-49.082M
50.08%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
-173.41M
-66.26%		-131.22M
24.33%		-109.154M
16.82%		-62.392M
42.84%
Operating Margin
-906.01%-170.28%-58.57%-19.30%
EPS
YoY % growth
-6.35
-55.64%		-4.02
36.74%		-3.97
1.17%		-1.25
68.44%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.49
38.93%
Revenue
Q2Q % growth		71.575M
126.50%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		-20.849MN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-24.517M
9.70%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.66
33.13%		-0.25-0.41-166.28%
Q3 2023
Q2Q % growth		 -0.57
44.12%		-0.640.0711.08%
Q2 2023
Q2Q % growth		 -1.94
-130.95%		-0.81-1.13-139.12%
Q1 2023
Q2Q % growth		 -0.80
31.62%		-0.960.1616.41%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 69.554M
149.21%		69.273M281K0.41%
Q3 2023
Q2Q % growth		 47.73M
154.15%		39.371M8.359M21.23%
Q2 2023
Q2Q % growth		 37.5M
114.53%		31.052M6.448M20.77%
Q1 2023
Q2Q % growth		 31.6M
145.15%		29.269M2.331M7.96%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-8.44% -316.12% -107.29% -432.02%
Revenue-1.3% -5.02% 0% -1.82%